What Second Messengers Are: cAMP, IP3, DAG and Calcium
A hormone or research peptide binds the outside of a cell and never gets in, yet transcription changes inside the nucleus. Four small intracellular molecules do most of that carrying work: cAMP, IP3, DAG and calcium. This explainer walks through what qualifies a molecule as a second messenger, how each of the four is generated, which effector proteins read it, how cells keep a diffusible signal local, and why every one of these pathways ships with a dedicated off switch.
by Research Assistant·
A research peptide lands on the outside of a cell, binds a receptor, and never crosses the membrane. Minutes later, transcription inside the nucleus has changed. Something carried the message inward — and across most of the signaling literature on compounds sold for research use only, that something is one of four small intracellular molecules: cAMP, IP3, DAG, or calcium. They're called second messengers, and learning their grammar makes an enormous amount of primary literature readable. This article is educational and covers laboratory research only; the compounds in that literature are research materials, not for human or animal use.
What follows is the full tour: what qualifies a molecule as a messenger, the cAMP branch from receptor to gene, the phospholipase C branch that gets two messengers out of one lipid, calcium's odd status as a messenger cells move rather than make, and why every pathway here ships with its own off switch.
What a Second Messenger Actually Is
Short version: a second messenger is the cell's internal courier — the molecule that delivers a message the receptor itself can't carry past the membrane.
That second criterion is worth pausing on. A courier only works if the mailbox is usually empty — which is why a messenger's off switch belongs to the system just as much as its on switch does.
Four classes are generally recognized: cyclic nucleotides (cAMP and cGMP), lipid messengers (DAG and PIP3), ions (calcium and magnesium), and gases and free radicals, including nitric oxide, carbon monoxide, and hydrogen sulfide. A second way of sorting them matters more for mechanism — sort by where they can travel. Hydrophilic messengers such as cAMP, cGMP, IP3, and Ca2+ move freely through the cytosol; hydrophobic ones such as DAG and the phosphatidylinositols stay in the membrane. One pathway, as we'll see, exploits exactly that difference.
Where the idea came from
Earl Sutherland showed that epinephrine acted on liver cells only by triggering cyclic AMP, work that earned the 1971 Nobel Prize; Martin Rodbell and Alfred Gilman later tied the mechanism to G proteins and shared the 1994 prize. The receptors that start most of this — nearly 800 GPCRs in the human genome, around 30% of identified drug targets — are still the busiest objects in signaling research. See our comparison of class B GPCRs studied by cryo-EM for how much structural detail now exists on the upstream end.
The cAMP Pathway: From Receptor to Gene Transcription
If you trace only one messenger end to end, trace this one. Every other pathway is a variation on the pattern cAMP set.
cAMP's best-studied reader is protein kinase A, and PKA's architecture is itself the mechanism. The enzyme rests as an inactive tetramer — two regulatory subunits, two catalytic subunits, with four regulatory types in play: RI-alpha, RI-beta, RII-alpha, and RII-beta. cAMP binds the regulatory subunits, the catalytic subunits are released, and they begin phosphorylating serine and threonine residues. The regulatory subunits are a lid, and cAMP lifts it.
One substrate finishes the trip to the nucleus. Phosphorylation of CREB at Ser133 is critical for its transcriptional activity; phosphorylated CREB then dimerizes, binds the cAMP response element in the promoter region of target genes, and starts transcription. That's the whole arc — a ligand that never entered the cell has changed which genes are being read.
Keeping it local
A freely diffusing messenger raises an obvious problem: how does a cell-wide signal produce a specific response? Anchoring is part of the answer. A-kinase anchoring proteins bind both PKA regulatory subunits and cytoskeletal proteins or organelles, spreading the kinase across compartments — PKA type I stays largely cytoplasmic while type II is anchored to defined subcellular structures. The same cAMP rise therefore hits different substrates depending on where the kinase is parked. cAMP also acts on Epac1 and Epac2 and on nucleotide-gated ion channels. One messenger, several readers, different outputs.
One Lipid, Two Messengers: IP3 and DAG
This is the elegant branch. A single enzymatic cut on one membrane lipid yields two messengers that then head in opposite directions.
The cut
Gq-coupled receptors activate phospholipase C-beta, which hydrolyzes phosphatidylinositol 4,5-bisphosphate — PIP2 — into inositol 1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG). Whether a given ligand drives this branch at all comes down to which G protein the receptor couples to, one reason coupling preference draws so much attention in structural work on peptide receptors.
IP3 goes soluble
IP3 is small and water-soluble, so it leaves the membrane immediately and diffuses through the cytosol to the endoplasmic reticulum. There it binds IP3 receptors, which are themselves calcium-release channels. Binding opens them, and calcium floods the cytosol. Note what the messenger acts on: not an enzyme, a gate.
DAG stays put
DAG does the opposite. Hydrophobic, it remains in the plasma membrane, where it recruits and activates protein kinase C.
The division of labor is the point: one cut yields a signal that fills the cytosolic volume and a second pinned to the membrane surface where the kinase has to dock. And because protein kinase C generally needs both DAG and the calcium IP3 released, the two halves reconverge on the same enzyme — a coincidence detector, built in.
Calcium: The Ion That Doubles as a Messenger
Calcium is the odd one out, and understanding why clarifies the whole category. Cells don't synthesize calcium. They move it. All of its signaling capacity comes from maintaining a gradient and then briefly letting it collapse.
Calcium reaches the cytosol through several distinct gates. On internal stores, IP3 receptors answer to the messenger described above, ryanodine receptors open in response to small molecules such as nitric oxide and caffeine, and two-pore channels serve the acidic organelles. At the plasma membrane, voltage-dependent calcium channels of the L-type, N-type, and T-type open when membrane potential changes. Chemical input, electrical input, or both can start a calcium signal.
Ways out
The clearance machinery is just as specific: plasma membrane calcium-ATPase, the SR/ER calcium-ATPase, the sodium/calcium exchanger, and the Na+/K+-ATPase together restore the resting gradient. A calcium rise is transient by construction — the pumps work against it the moment it starts.
What calcium talks to
Calmodulin is the canonical reader: semi-activated on Ca2+ binding, fully activated after phosphorylation, then handing the signal to downstream kinases and phosphatases. Timing and location carry information too. Calcium waves cross a cell in a saltatory manner, through successive rounds of calcium-induced calcium release and diffusion, so a signal travels further than any single molecule diffuses.
Conventional PKCs (alpha, beta-I, beta-II, gamma) need both calcium, bound at a C2 domain, and DAG, bound at twin C1A/C1B domains. They fire only when both messengers are present.
Novel PKCs (delta, theta, epsilon, eta) have C2 domains that lack the critical calcium-coordinating acidic residues, making them calcium-independent. DAG alone is enough.
Atypical PKCs (zeta, iota/lambda) carry a single atypical C1 domain that binds PIP3 or ceramide rather than DAG, and no calcium-sensitive C2 domain at all.
The domains themselves
Each C1 domain contains six cysteines and two histidines coordinating two zinc ions, and works as the DAG-binding motif. Holding the enzyme off until the messengers arrive is an autoinhibitory pseudosubstrate sequence — a stretch that looks like a substrate but carries an alanine where the phosphoacceptor would be, so it occupies the active site without being modified.
The practical takeaway when reading papers: "PKC activation" is never one event. Which isoform translocates tells you which messengers were there.
Refilling the Store: STIM1 and Orai1
A messenger released from a finite store has to be replaced, and cells have a sensor dedicated to that exact problem.
What happens next is mechanical. The two EF-SAM domains dimerize, pulling the transmembrane segments together into a coiled-coil, and the CC1-alpha-1 domain that normally sequesters CAD/SOAR near the ER membrane lets go. The cytosolic domain then extends by as much as 15 nm, reaching the CRAC activation domain toward the plasma membrane like an arm unfolding.
Opening Orai1
Orai works as a hexamer of four-transmembrane subunits, with six TM1 helices lining the entire ion permeation pathway — a selectivity filter, a 15 angstrom hydrophobic region, and a 15 angstrom basic region. Gating is a rotation. Roughly 20 degrees of TM1 movement swings the F99 side chains out of the lumen so water can enter, and a coupled rotation of the selectivity filter at E106 configures the calcium binding site for selectivity. Calcium entering through those channels refills the ER and resets STIM1 to its inactive dimeric state.
Turning the Signal Off Is Part of the Design
Every messenger in this article has a dedicated shutdown mechanism, and in practice the off switches are as informative as the on switches — they set how long a signal lasts and how sharply it can repeat.
Four layers of shutdown
The G protein switch. The G-alpha subunit has intrinsic GTPase activity and hydrolyzes GTP back to GDP, ending its own output; RGS proteins speed that deactivation up.
Cyclic nucleotide clearance. Phosphodiesterases hydrolyze cAMP and cGMP, and at least 22 PDEs have been identified. Intracellular cAMP concentration is the running balance between the cyclases making it and the PDEs clearing it.
Calcium clearance. The ATPases and exchangers above pull cytosolic calcium back to its resting level.
Negative feedback. Activated PKA inhibits adenylyl cyclase AC5 and AC6 while activating PDE3 and PDE4 — the messenger's own reader throttling its production.
Fade at the receptor
Shutdown also happens upstream of any messenger. Phosphorylation of receptor cytoplasmic domains causes desensitization, followed by beta-arrestin-mediated internalization through clathrin-coated pits. That's why receptor desensitization in cultured cells is a routine confound rather than an edge case, and why a flat second-messenger readout sometimes says more about the receptor than about the compound.
Frequently Asked Questions
What is the difference between a first messenger and a second messenger?
A first messenger is the extracellular signal itself — a hormone, neurotransmitter, or peptide that binds a surface receptor and usually never enters the cell. A second messenger is the small intracellular molecule or ion the cell produces or releases in response, carrying the message inward to effector proteins. cAMP, IP3, DAG, and calcium are second messengers; epinephrine and GLP-1 are first messengers. The split explains how a signal that cannot cross the membrane still changes what happens in the nucleus.
Why do cells use second messengers instead of a direct connection?
Amplification and flexibility. One activated receptor can drive an enzyme that makes thousands of messenger molecules, and in a typical cell roughly 300 to 500 distinct proteins can be phosphorylated by protein kinase A alone — so a handful of binding events becomes a cell-wide response. Flexibility comes from reuse: the same messenger can be produced by many receptors and read by many effectors, which lets a cell combine inputs rather than wire each signal separately.
Are cAMP, IP3, DAG, and calcium the only second messengers?
No. They are the most studied, but the recognized set also includes cGMP, PIP3, sphingolipid messengers such as ceramide and sphingosine 1-phosphate, eicosanoids derived from arachidonic acid, and gaseous messengers including nitric oxide, carbon monoxide, and hydrogen sulfide. Structurally the group splits into water-soluble messengers that diffuse through the cytosol and membrane-associated lipid messengers that stay in the bilayer.
How does a diffusible messenger produce a specific response?
Through spatial organization. Calcium microdomains are the clearest case: synaptotagmin responds only within a few tens of nanometers of a channel, while calmodulin and SK channels respond at greater distances. Location, not just concentration, carries information.
Putting It All Together
Four messengers — cAMP, IP3, DAG, and calcium — plus one shared grammar of production, reading, spatial confinement, and shutdown account for most of the receptor mechanism described in peptide and GPCR literature. When a study says a compound "signals through Gq" or "raises intracellular calcium," you already know which cascade is meant; the interesting question is usually which isoform moved, or which compartment the signal stayed in, rather than whether the messenger rose at all.
It's also a moving target. Structural work on STIM and Orai, and on receptor-G protein complexes, keeps raising the bar for what counts as a complete mechanism — a good argument for reading the primary literature directly rather than summaries of it.
For research use only. Not for human or animal
consumption of any kind. The information in this article is for
educational purposes only and is not intended to diagnose, treat,
cure, or prevent any disease. The statements made have not been
evaluated by the U.S. Food and Drug Administration. These products
are NOT FDA APPROVED. Please consult with a licensed healthcare
professional before making any decisions regarding your health
or research.
Optides LLC is a chemical supplier. Optides LLC is not a
compounding pharmacy or chemical compounding facility as defined
under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC
is not an outsourcing facility as defined under 503B of the Federal
Food, Drug, and Cosmetic Act.
Tags
Second MessengersCell SignalingGpcrCalcium SignalingProtein KinaseResearch Peptides
Stay In The Loop
Stay Updated on New Research Compounds
Be the first to know about new products, research guides, and exclusive offers.